Study guide

16.2 Great Vessels, Venous Return, and Pulmonary Artery Assessment

CCI Registered Cardiac Sonographer RCS

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: RCS Orientation and Clinical Context

1.1 RCS Identity, Exam Format, Application, and Retesting 1.2 Clinical History, Symptoms, Indications, and Risk Factors 1.3 Prior Studies, Serial Change, and Cross-Modality Context

2 Chapter 2: Orders, Safety, and Patient Preparation

2.1 Order Verification, Scope, and Protocol Selection 2.2 Sonographer Ergonomics and Staff Safety 2.3 Patient Preparation, Positioning, Consent, Infection Control, and Aftercare

3 Chapter 3: Reporting and 2-D TTE Foundations

3.1 Structured Findings, Significant Results, and Escalation 3.2 Standard 2-D TTE Windows, Views, and Acquisition Sequence 3.3 2-D Measurements, Foreshortening, Image Quality, and QA

4 Chapter 4: M-Mode and Doppler Acquisition

4.1 M-Mode Alignment, Timing, Measurements, and Pitfalls 4.2 Color Doppler Acquisition, Scale, Gain, and Jet Display 4.3 PW and CW Spectral Doppler Acquisition

5 Chapter 5: Advanced Doppler and Contrast

5.1 Tissue Doppler and Hemodynamic Sample Placement 5.2 Ultrasound-Enhancing Agents and LV Opacification 5.3 Agitated-Saline Studies and Intracardiac Shunts

6 Chapter 6: Stress Echocardiography

6.1 Exercise Stress Echo Protocols and Peak Imaging 6.2 Pharmacologic Stress Echo, Dobutamine, and Safety 6.3 Non-Ischemic Stress Echo and Hemodynamic Provocation

7 Chapter 7: TEE, Strain, and 3-D TEE

7.1 Assisting TEE: Preparation, Probe Safety, Views, and Complications 7.2 Strain Acquisition, Tracking Quality, and Reproducibility 7.3 3-D TEE Acquisition, Cropping, Orientation, and Artifacts

8 Chapter 8: 3-D TTE and the Aortic Valve

8.1 3-D TTE Full-Volume Acquisition and Quantitation 8.2 Aortic-Valve Anatomy, Morphology, and Function 8.3 Aortic Stenosis: Velocities, Gradients, Valve Area, and Flow States

9 Chapter 9: Aortic Regurgitation and Mitral Structure

9.1 Aortic Regurgitation Mechanisms and Integrated Severity 9.2 Mitral-Valve Anatomy, Motion, and Mechanisms 9.3 Mitral Stenosis: Planimetry, Gradients, Pressure Half-Time, and Suitability

10 Chapter 10: Mitral and Tricuspid Valve Findings

10.1 Mitral Regurgitation Mechanism, Quantitation, and Severity Integration 10.2 Tricuspid-Valve Anatomy, Structure, and Function 10.3 Tricuspid Stenosis Assessment

11 Chapter 11: Right-Sided Valve Disease

11.1 Tricuspid Regurgitation Mechanism and Severity 11.2 Pulmonic-Valve Anatomy, Structure, and Function 11.3 Pulmonic Stenosis Assessment

12 Chapter 12: Pulmonic Regurgitation and Prosthetic Valves

12.1 Pulmonic Regurgitation Mechanism and Severity 12.2 Normal Mechanical and Bioprosthetic Valve Assessment 12.3 Prosthetic Obstruction, Regurgitation, Thrombosis, and Patient–Prosthesis Mismatch

13 Chapter 13: Endocarditis and Cardiac Chambers

13.1 Valvular Endocarditis, Vegetations, Abscess, and Complications 13.2 LV and LA Size, Geometry, Volumes, Mass, and Function 13.3 RV and RA Size, Pressure, Volume, and Function

14 Chapter 14: Cardiomyopathy Phenotypes and Diastology

14.1 Dilated and Hypertrophic Cardiomyopathies, SAM, and LVOT Obstruction 14.2 Restrictive, Arrhythmogenic, and Stress Cardiomyopathies 14.3 Diastolic Function, Filling Pressure, Grading, and Pitfalls

15 Chapter 15: Systolic Function and Ischemia

15.1 LV Systolic Function, Simpson EF, Regional Motion, and Output 15.2 RV Systolic Function: TAPSE, S-prime, FAC, and Coupling 15.3 Ischemic Heart Disease, Coronary Territories, Stress Response, and Complications

16 Chapter 16: Pericardium and Great Vessels

16.1 Pericardial Effusion, Tamponade, Constriction, and Doppler Physiology 16.2 Great Vessels, Venous Return, and Pulmonary Artery Assessment 16.3 Aortic Root, Aneurysm, Dissection, and Coarctation

17 Chapter 17: Pulmonary Pressure, Masses, and Congenital Recognition

17.1 Pulmonary Hypertension, RAP/PASP Estimation, and RV Consequences 17.2 Cardiac Masses, Thrombus, Tumor, Vegetation, and Mimics 17.3 Adult Recognition of ASD, VSD, PFO, PDA, and Congenital Clues

18 Chapter 18: Devices, Strain, and Hemodynamics

18.1 ICDs, Pacemakers, Occluders, Closure Devices, and Mechanical Support 18.2 Strain Interpretation, Global Longitudinal Strain, and Disease Patterns 18.3 Cardiac Hemodynamics, Bernoulli, Continuity, Stroke Volume, and Shunts

19 Chapter 19: Infiltrative Disease and Physics Foundations

19.1 Amyloid, Sarcoid, and Other Infiltrative Disease Patterns 19.2 Ultrasound Wave Properties, Propagation, Frequency, and Wavelength 19.3 Artifact Recognition: Reverberation, Shadowing, Mirror, Refraction, and Aliasing

20 Chapter 20: Resolution and Doppler Optimization

20.1 Axial/Lateral Resolution, Frame Rate, Depth, Focus, and Trade-Offs 20.2 Spectral Doppler Optimization, Nyquist, Filters, Gain, and Angle 20.3 Color Doppler Optimization, Scale, Priority, Variance, and Gain

21 Chapter 21: 2-D, 3-D, and Contrast Optimization

21.1 2-D Optimization: Frequency, Gain, TGC, Harmonics, Depth, and Focus 21.2 3-D Optimization: Volume Rate, Stitching, Cropping, and Display 21.3 Contrast Optimization: Mechanical Index, Destruction, Replenishment, and Artifacts

16.2 Great Vessels, Venous Return, and Pulmonary Artery Assessment

Key Takeaways Explain This Topic AI

Follow blood flow segment by segment through the RVOT, pulmonary valve, main and branch pulmonary arteries, pulmonary veins, systemic veins, and right atrium, confirming every suspected abnormality in a second view.

Measure the main pulmonary artery in end diastole halfway between the pulmonic valve and bifurcation; preserve segment, phase, plane, edge convention, and modality in serial comparisons.

Use color to locate acceleration, PW to map its level and obtain VTI or acceleration time, and aligned CW to record the highest velocity; no isolated diameter or Doppler feature diagnoses pulmonary hypertension.

Assess IVC and hepatic-vein behavior with respiration, and treat incomplete visualization of pulmonary or systemic venous connections as a limitation rather than proof of anomalous return.

Last updated: July 2026

Use a flow-path map rather than an isolated measurement

CCI task D7 covers great vessels, venous return, and pulmonary artery assessment. Trace the right-sided pathway from RV inflow through the RV body, infundibulum, pulmonary valve, main pulmonary artery (MPA), bifurcation, and proximal right and left pulmonary arteries. Then trace pulmonary venous return to the LA and systemic venous return through SVC, IVC, hepatic veins, and coronary sinus to the RA. This map prevents a high velocity, dilated segment, or unexpected color jet from being assigned to the wrong structure. Confirm unusual connections in orthogonal views.

Use parasternal short-axis at the aortic valve and a pulmonary-artery-focused modification to show distal RVOT, pulmonary valve, MPA, and bifurcation. A high left parasternal or suprasternal window may improve branch arteries; subcostal views help in congenital anatomy. Measure distal RVOT at end diastole just proximal to the annulus. Measure MPA at end diastole, perpendicular to its long axis, halfway between the pulmonic valve and bifurcation; measure proximal RPA and LPA in the same phase. A TTE MPA diameter above 25 mm is abnormal in adults but nonspecific: pressure or volume overload, shunts, valve disease, altered body size, and normal variation must be considered.

Target Preferred acquisition Main interpretive use

MPA and bifurcation PA-focused parasternal short axis; end-diastolic diameter midway to bifurcation Dilation, stenosis, poststenotic change, branch origin

RVOT/PV flow PW sample 1–2 mm below valve; color mapping before CW VTI, acceleration time, obstruction level, regurgitation

IVC Subcostal long axis plus transverse confirmation Diameter and respiratory change supporting RA pressure estimate

Hepatic vein PW 1–2 cm from IVC junction over respiration S/D flow, atrial reversal, systolic reversal, respiratory diastolic reversal

Pulmonary vein Color-guided apical PW about 10 mm proximal to LA S, D, and atrial-reversal waveform and venous connection

Localize pulmonary-artery and RVOT findings

Color Doppler first identifies aliasing or regurgitation. Step PW through the RVOT and across accessible segments to locate acceleration, then use aligned CW for the highest velocity when obstruction is suspected. Place a small PW sample 1–2 mm below the pulmonary valve to acquire a clean RVOT VTI and acceleration time (AccT), measured from flow onset to peak. An AccT above 105 ms is generally normal; shortening or midsystolic notching can support increased pulmonary vascular impedance but is not diagnostic of pulmonary hypertension. Heart rate, stroke volume, RV dysfunction, sampling location, respiration, and technical filtering alter the contour.

Inspect the pulmonary valve in 2-D for leaflet number, doming, mobility, and annular size. A narrow aliasing origin at the valve differs from subvalvar infundibular acceleration or supravalvar/branch stenosis. Preserve each PW sample location in labeled clips so the CW envelope has an anatomic source. In suspected shunt physiology, combine pulmonary and systemic flow calculations only when both outflow diameters and VTIs are technically valid; small diameter errors are squared and can dominate the ratio.

Interpret the MPA and RVOT with TR velocity or PASP, PR end-diastolic velocity when valid, RV size and function, RA size, septal flattening, shunt search, and valve morphology. A dilated MPA with normal pressure estimates may reflect prior or volume loading; a normal MPA does not exclude pulmonary hypertension. Report the exact segment and whether a velocity is proximal, valvar, supravalvar, or branch-level. If comparing CT, CMR, and echo, do not treat unlike phases, planes, or edge conventions as true growth.

Examine systemic and pulmonary venous return

Image the IVC in subcostal long axis and measure at end expiration 0.5–3.0 cm proximal to the RA ostium and distal to the hepatic-vein junction. Observe quiet breathing and a sniff, and confirm that apparent caliber change is not translation out of plane; a transverse view can verify the maximum diameter. IVC size and collapse support an RA-pressure category but are less reliable with positive-pressure ventilation, abnormal respiratory effort, athletic remodeling, or chronic right-heart disease. Hepatic-vein PW across a full respiratory cycle adds systolic and diastolic filling information and can reveal systolic reversal with severe TR or expiratory diastolic reversal with constriction.

Visualize the SVC from subcostal, right supraclavicular, or modified apical views when indicated. A dilated coronary sinus should prompt consideration of a persistent left SVC. With an authorized agitated-saline study, left-arm injection entering the coronary sinus before the RA supports that connection; compare with right-arm injection and exclude unroofed coronary sinus or other shunts before concluding anatomy. Interrupted IVC with azygos continuation may show absent hepatic continuity and a prominent posterior mediastinal vein. CT or CMR usually maps systemic venous variants more completely.

Use color to locate pulmonary veins and place PW about 10 mm proximal to the LA, commonly in the right upper pulmonary vein from an apical view. A normal waveform commonly has systolic, diastolic, and atrial-reversal components, but rhythm, age, MR, LA pressure, and sampling depth alter it. Attempt multiple views to document venous connections. Failure to see all four veins does not prove partial anomalous pulmonary venous return; unexplained right-heart volume overload, an atypical vein course, or sinus venosus defect should trigger additional imaging.

A complete report names each visualized segment, connection, diameter with phase and convention, direction and character of flow, obstruction or regurgitation, and technical limitation. Promptly communicate suspected acute pulmonary-artery obstruction, severe RV pressure overload with deterioration, or a critical congenital/iatrogenic connection, while recommending definitive CT, CMR, or TEE according to stability and local protocol.